Records containing: HIV Infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-06-10A Randomized, Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection
-
CLINICAL_TRIALS study record update · 2015-06-02The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk
-
CLINICAL_TRIALS study record update · 2015-05-28Efficacy of a Computerised Physician Reminder System to Control Cardiovascular Risk Factors in HIV-infected Patients Receiving Antiretroviral Therapy: A Nested Randomised Controlled Cluster Trial Within the Swiss HIV Cohort Study
-
CLINICAL_TRIALS study record update · 2015-05-19An Evaluation of the Pharmacological Interaction of Lopinavir 800mg - Ritonavir 200mg Combination and Rifampin in Subjects Presenting Tuberculosis, With Contraindication for Antiretroviral Regimens Including Efavirenz
-
CLINICAL_TRIALS study record update · 2015-05-18Decay Kinetics of HIV With the Integrase Inhibitor Raltegravir
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-05-12Efficacy of Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy in Patients With Viral Suppression. Randomized, Open-label 96 Weeks Non-inferiority Trial
-
CLINICAL_TRIALS study record update · 2015-05-12A Phase 2b Randomized, Double-Blind, Double-Dummy Trial of 100 or 200 mg Once-Daily Doses of Cenicriviroc (CVC, TBR-652) or Once-Daily EFV, Each With Open-Label FTC/TDF, in HIV-1-Infected, Antiretroviral Treatment-Naïve, Adult Patients With Only CCR5-Tropic Virus
-
CLINICAL_TRIALS study record update · 2015-04-08A Phase IV, Open-label, Multicenter Study of Treatment With TRIZIVIR (Abacavir 300mg/Lamivudine 150mg/Zidovudine 300mg) Twice Daily and Tenofovir 300mg Once-daily for 48 Weeks in HIV-infected Subjects Experiencing Early Virologic Failure (ZIAGEN Intensification Protocol)
-
CLINICAL_TRIALS study record update · 2015-04-07A Medication Adherence Intervention for HIV Infected Veterans
-
CLINICAL_TRIALS study record update · 2015-04-01Open Randomized Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: TENOFOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC
-
CLINICAL_TRIALS study record update · 2015-04-01Open Randomized Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir
-
CLINICAL_TRIALS study record update · 2015-04-01A Double-blind Phase I Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART
-
CLINICAL_TRIALS study record update · 2015-04-01Virological and Clinical Anti-HBV Efficacy of Tenofovir in Antiretroviral naïve Patients With HIV/HBV Co-infection
-
CLINICAL_TRIALS study record update · 2015-03-30Open-label Randomized Multicenter Study of Once Daily Antiretroviral Treatment Regimen Comparing Ritonavir Boosted Atazanavir to Efavirenz
-
CLINICAL_TRIALS study record update · 2015-03-18Evaluating a Microfinance Intervention for High Risk Women in Mongolia
-
CLINICAL_TRIALS study record update · 2015-03-13A Phase 1 Dose Escalation, Single Dose Study of Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-278 in HIV-Infected Patients Who Have Exhibited Suboptimal CD4+ T-Cell Gains During Long-Term Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2015-03-06A Randomized Trial of IUD Versus Hormonal Contraception in HIV-infected Women in Zambia
-
CLINICAL_TRIALS study record update · 2015-03-04The Latex Diaphragm to Prevent HIV Acquisition Among Women: A Female-Controlled, Physical Barrier of the Cervix
-
CLINICAL_TRIALS study record update · 2015-01-14Phase II Clinical Trial to Evaluate the Antiviral Activity of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in Individuals With Chronic Hepatitis Due to HCV Genotype 4 and Coinfected by HIV
-
CLINICAL_TRIALS study record update · 2014-12-23Post-marketing Safety Surveillance Program in HIV-infected Children Exposed to Atazanavir in Europe
-
CLINICAL_TRIALS study record update · 2014-12-23Study of Immunological, Virological, Serological Characteristics of HIV+ Patients Harboring Isolated Anti-HBc Profile and Response to Hepatitis B Vaccination
-
CLINICAL_TRIALS study record update · 2014-12-08Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
-
CLINICAL_TRIALS study record update · 2014-12-04Evaluation of Barriers to Postpartum Care in HIV Infected Women
-
CLINICAL_TRIALS study record update · 2014-11-06A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL) Each Administered With a Background Regimen in HIV-1 Infected, Antiretroviral Treatment-Experienced Adults
-
CLINICAL_TRIALS study record update · 2014-11-04A Phase III, Open-label, Single Centre, Single-arm, Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Efavirenz With Continuing Central Nervous System (CNS) Toxicity, to Raltegravir